Results 81 to 90 of about 69,163 (114)
Some of the next articles are maybe not open access.

Related searches:

Valores de referencia de la actividad enzimática alfa-glucosidasa ácida linfocitaria

Revista Del Laboratorio Clínico, 2016
Borja del Castillo Figueruelo   +3 more
exaly   +2 more sources

Inhibición de la enzima alfa glucosidasa por los extractos etanólicos de canela y clavo de olor: estudio in vitro

Revista Peruana de Medicina Integrativa, 2023
Introducción: Syzygium aromaticum (clavo de olor) y Cinnamomum zeylanicum (canela) son plantas usadas tradicionalmente por sus propiedades antioxidantes, antiinflamatorias, digestivas e hipoglucémicas que ayudan a disminuir el apetito y a controlar los ...
José Aranda-Ventura   +2 more
semanticscholar   +1 more source

Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684

Journal of Clinical Oncology, 2023
PURPOSE Interferon alfa-2b (IFN alpha-2b) exhibits antitumor activity in metastatic melanoma and on this basis has been evaluated as an adjuvant therapy following surgery for deep primary (T4) or regionally metastatic (N1) melanoma.
J. M. Kirkwood   +5 more
semanticscholar   +1 more source

Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study.

Lancet Neurology
BACKGROUND Cerliponase alfa is a recombinant human tripeptidyl peptidase 1 (TPP1) enzyme replacement therapy for the treatment of neuronal ceroid lipofuscinosis type 2 (CLN2 disease), which is caused by mutations in the TPP1 gene.
A. Schulz   +16 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy